Biopharmaceuticals
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
Aim & Scope
This section is dedicated to research on the therapeutic, diagnostic, prognostic and immunoprophylactic developments of important biological macromolecules built from amino acids, sugars, nucleic acids, comprising small basic units of which they are composed, and mimetics produced by chemical synthesis. Contributions focusing on biopharmaceutical applications of more complex entities, such as phages, viruses, exosomes and stem cells, among others, are also welcome. Also reports on structure and molecular interactions determinant for biopharmaceuticals bioactivity or pharmaceutical applications, e.g. by computational and NMR studies are also accepted. Download Section Flyer
Keywords
- Peptides
- Proteins
- RNA
- DNA
- Nucleic Acids
- Aptamers
- Carbohydrates
- Glycans
- Polysaccharides
- Macromolecules
- Chemical Synthesis
- Ribonucleoproteins
- Antibodies
- Phages
- Viruses
- Therapeutic Tools
- Peptidomimetics
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Organ Regeneration by Application of Biomaterials and Stem Cells Technology Tools (Deadline: 12 July 2025)
- 2D and 3D Culture Systems: Current Trends and Biomedical Applications (Deadline: 25 July 2025)
- Stem Cells in Oncology: Emerging Targets for Therapy (Deadline: 31 August 2025)
- Peptide Drug Conjugates and Their Applications (Deadline: 20 September 2025)
- Therapeutic Applications of Micro-RNA in Cancer Management (Deadline: 25 September 2025)
- Protein and Peptide-Based Drug Delivery (Deadline: 20 November 2025)
- Antiplatelet Therapy in Inflammatory Diseases (Deadline: 20 November 2025)
- Peptide Synthesis and Drug Development: Exploring Progress and Potential (Deadline: 25 November 2025)
- Advances in Non-Coding RNAs as Prognostic Biomarkers, Therapeutic Targets, and Regulatory Mechanisms in Cancer (Deadline: 25 December 2025)
- Exosome and Biotherapeutic Strategies for Dermatological and Oncological Skin Complications (Deadline: 25 December 2025)
- Characterization and Quality Control of Biopharmaceuticals Using the Multi-Attribute Method (MAM): Advantages and Challenges (Deadline: 31 December 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
